Product Information

ERYTHROMYCIN 0.5% EYE OINTMENT is a generic product labeled by Bausch & Lomb Incorporated, priced at $6.7160 per GM under NDC 24208091019. Its NADAC has been published 228 times since May 17, 2017.

FDA first approved this application on Jul 29, 1994. Its Orange Book therapeutic-equivalence code is AT.

ERYTHROMYCIN 0.5% EYE OINTMENT

Erythromycin
$6.7160per GM

Strength

5 mg/g

NDC

24208091019

Classification

Generic

Dosage Form

OINTMENT

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

ERYTHROMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA064067

FDA Approved

7/29/1994

TE Code

AT

On Market Since

7/29/1994

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price Statistics

The NADAC for ERYTHROMYCIN 0.5% EYE OINTMENT has been published 228 times since May 17, 2017, and over the history we have for it it has declined 5.5%. The table below summarizes its recorded NADAC range and movement.

Current price$6.7160 per GM
All-time high$7.6426 (Sep 10, 2025)
All-time low$3.4370 (May 22, 2024)
52-week high$7.6426
52-week low$6.1653
Median price$6.3254
Average price$5.8726
Largest weekly change-32.8% (Apr 17, 2024)
Weeks tracked228
Tracking sinceMay 17, 2017

Price History

1W

+6.2%

1M

+6.2%

3M

+6.2%

6M

+6.7%

1Y

-12.1%

3Y

+25.3%

5Y

+25.3%

All

-5.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ERYTHROMYCIN 0.5% EYE OINTMENT?

The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 0.5% EYE OINTMENT, manufactured by Bausch & Lomb Incorporated, is $6.7160 per GM (NDC 24208091019), effective Aug 19, 2026.

How has the price of ERYTHROMYCIN 0.5% EYE OINTMENT changed over time?

Over the history we have for it, the NADAC for ERYTHROMYCIN 0.5% EYE OINTMENT has declined 5.5%. It has been tracked across 228 weekly CMS publications since May 17, 2017.

What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 0.5% EYE OINTMENT?

Since May 17, 2017, the NADAC for ERYTHROMYCIN 0.5% EYE OINTMENT has ranged from a low of $3.4370 (May 22, 2024) to a high of $7.6426 (Sep 10, 2025), with a median of $6.3254 per GM.

Are there cheaper alternatives to ERYTHROMYCIN 0.5% EYE OINTMENT?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN 0.5% EYE OINTMENT, is $2.8339 per GM — about 58% below ERYTHROMYCIN 0.5% EYE OINTMENT.

Who manufactures ERYTHROMYCIN 0.5% EYE OINTMENT?

ERYTHROMYCIN 0.5% EYE OINTMENT (NDC 24208091019) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.